DUBLIN--(BUSINESS WIRE)--Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation ...
DUBLIN, February 20, 2025--Prothena reported financial results for the 4th quarter and full year 2024. The Company also provided business highlights and 2025 financial guidance. DUBLIN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback